Delyan Ivanov

Delyan Ivanov is an experienced professional in the pharmaceutical industry, currently serving as Associate Director of High Throughput Screening at AstraZeneca since November 2016, where leadership of a high-performing team focuses on delivering small molecule hits through in vitro cell screens. Previous roles at AstraZeneca include Senior Research Scientist positions, where contributions involved integrating data science and biology, developing machine learning techniques to enhance drug discovery processes, and improving safety predictions through advanced screening methods. Prior to AstraZeneca, Delyan was an EPSRC Doctoral Prize Postdoctoral Fellow at the University of Nottingham, establishing assays for neurotoxicity testing and supervising junior researchers, and completed a PhD in Pharmacy at the same institution. Initial career experience includes a Quality Control Manager role at Kendy Ltd and an industrial placement at Actavis, gaining expertise in manufacturing processes and regulatory compliance.